Skip to main content
. 2022 Jan 26;14(3):616. doi: 10.3390/cancers14030616

Figure 3.

Figure 3

Survival by count recovery from end of induction I (EOI1). (A) Disease-free survival (DFS) and (B) overall survival (OS) from EOI1 are reported according to count recovery parameters in patients with <5% bone marrow blasts by central ΔN flow cytometry who received Induction I and II therapy in AAML0531 and AAML1031.